BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20189046)

  • 1. TREAT versus treatment: a patient's view of a scientific interpretation.
    Prisant A
    Am J Kidney Dis; 2010 Mar; 55(3):A31-2. PubMed ID: 20189046
    [No Abstract]   [Full Text] [Related]  

  • 2. Does TREAT give the boot to ESAs in the treatment of CKD anemia?
    Singh AK
    J Am Soc Nephrol; 2010 Jan; 21(1):2-6. PubMed ID: 20035034
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.
    Vaziri ND; Zhou XJ
    Nephrol Dial Transplant; 2009 Apr; 24(4):1082-8. PubMed ID: 18987263
    [No Abstract]   [Full Text] [Related]  

  • 4. Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting.
    Winkelmayer WC
    J Am Soc Nephrol; 2011 Jan; 22(1):1-2. PubMed ID: 21164031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Would prescription of erythropoiesis-stimulating agents in pre-dialysis change after results from TREAT study?].
    Alcázar R; Tato A; García F; Barrios V; Quereda C
    Nefrologia; 2010; 30(1):114-8. PubMed ID: 20038963
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody-mediated acquired pure red cell aplasia (PRCA) after treatment with darbepoetin.
    Howman R; Kulkarni H
    Nephrol Dial Transplant; 2007 May; 22(5):1462-4. PubMed ID: 17314208
    [No Abstract]   [Full Text] [Related]  

  • 7. An ongoing study of anemia correction in chronic kidney disease.
    Pfeffer MA;
    N Engl J Med; 2007 Mar; 356(9):959-61. PubMed ID: 17329707
    [No Abstract]   [Full Text] [Related]  

  • 8. Post transplantation anemia: re-emphasizing the use of erythropoietin.
    Jabur WL
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):104-6. PubMed ID: 21196622
    [No Abstract]   [Full Text] [Related]  

  • 9. The KDIGO anemia guideline: can reason triumph over regulation?
    Wish JB
    Nephrol News Issues; 2012 Dec; 26(13):20, 22-3. PubMed ID: 23346853
    [No Abstract]   [Full Text] [Related]  

  • 10. Is it safe to use erythropoiesis-stimulating agents to treat anemia in chronic kidney disease patients with active malignancies?
    Gupta G; Choi MJ
    Semin Dial; 2011; 24(4):379-81. PubMed ID: 21801225
    [No Abstract]   [Full Text] [Related]  

  • 11. Racial differences in erythropoietin responsiveness.
    Kaufman JS
    Am J Kidney Dis; 2008 Dec; 52(6):1035-8. PubMed ID: 19026356
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of anemia in chronic kidney disease: understandings in 2006.
    Levin A
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):267-71. PubMed ID: 17420672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of anemia in chronic kidney disease--strategies based on evidence.
    Marsden PA
    N Engl J Med; 2009 Nov; 361(21):2089-90. PubMed ID: 19880845
    [No Abstract]   [Full Text] [Related]  

  • 14. Aranesp (darbepoetin alfa): a new erythropoiesis-stimulating protein.
    Chmielewski C
    Nephrol Nurs J; 2002 Feb; 29(1):67-8. PubMed ID: 11887490
    [No Abstract]   [Full Text] [Related]  

  • 15. Debate: PRO Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?
    Singh AK
    Am J Nephrol; 2010; 31(6):552-6; discussion 563-4. PubMed ID: 20501988
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial perspective. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?
    Parfrey PS
    Am J Nephrol; 2010; 31(6):565-6. PubMed ID: 20501992
    [No Abstract]   [Full Text] [Related]  

  • 17. Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA).
    Goldsmith D; Covic A
    Nephrol Dial Transplant; 2010 Jun; 25(6):1734-7. PubMed ID: 20200007
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic kidney disease anemia management: what should be done?
    Szczech LA
    Blood Purif; 2011; 31(1-3):186-8. PubMed ID: 21228588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Darbepoetin alfa (Aranesp) for treating anemia associated with chronic kidney disease.
    Kosier JH; Newton M; Combest W; Gaines KK
    Urol Nurs; 2003 Feb; 23(1):77-8. PubMed ID: 12677723
    [No Abstract]   [Full Text] [Related]  

  • 20. Anemia in the older adult. Engineering George's road to better health.
    Henderson MJ
    Adv Nurse Pract; 2007 Jun; 15(6):55-6, 58. PubMed ID: 19999010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.